Evidence map›Paper›PMID 35242605›Full record

ArticleSchizophrenia research. Cognition2022

An examination of neurocognition and theory of mind as predictors of engagement with a tailored digital therapeutic in persons with serious mental illness.

Tate F Halverson, Julia Browne, Samantha M Thomas, Paige Palenski, Roger Vilardaga

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research. Cognition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Tate F HalversonDurham VA Health Care System, Durham, NC, United States of America.
Julia BrowneDurham VA Health Care System, Durham, NC, United States of America.
Samantha M ThomasDuke Cancer Institute, Duke University, Durham, NC, United States of America.
Paige PalenskiDepartment of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, AL, United States of America.
Roger VilardagaDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, United States of america.
Duke University · USGeriatric Research Education and Clinical Center · USMental Illness Research, Education and Clinical Centers · USUniversity of Alabama at Birmingham · US

Funding

Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness.R01DA047301 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI VILARDAGA, ROGER · 2020 to 2024
$3.4M
Increasing the population-level impact of a digital therapeutic for smokers with psychiatric illnessK02DA054304 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Roger Vilardaga · 2022 to 2026
$629k
NIDA NIH HHS K02 DA054304NIDA NIH HHS R01 DA047301
6 · The paper itself

Abstract

There is an increasing interest in the development and implementation of digital therapeutics (apps) in individuals with serious mental illness (SMI). However, there is limited understanding of the role of neurocognition and social cognition on engagement with apps. The present study is a secondary analysis of a pilot randomized controlled trial (

Indexed as

CigaretteCognitionDigital therapeuticmHealthSerious mental illnessTobacco

Identifiers

PMID35242605
PMCPMC8861409
OpenAlexW4205915186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.